SCHEMBL31429052

SCHEMBL31429052

CC(C)(C)OC(=O)C1CCN(C(=O)c2ccc3nc(C=O)cc(-c4ccccc4-c4ccccc4)c3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.43
KMT2A Q03164 3/20 0.41
NPC1 O15118 1/20 0.41
HSP90AA1 P07900 1/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.39
ACACB O00763 2/20 0.39
ACACA Q13085 2/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 2/20 0.38
PDK2 Q15119 1/20 0.38
MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428571 0.89 HPGD (0.45) HPGDKMT2ANPC1HSP90AA1RAB9A
SCHEMBL31428573 0.85 HPGD (0.37) HPGDKMT2ANPC1HSP90AA1RAB9A
SCHEMBL24976120 0.82 MAPT (0.57) HPGDKMT2ANPC1RAB9ACYP2C9
SCHEMBL31428817 0.82 MAPT (0.57) HPGDKMT2ANPC1RAB9ACYP2C9
SCHEMBL24977054 0.81 ABCG2 (0.47) KMT2ANPC1RAB9AALDH1A1MEN1
SCHEMBL31428706 0.81 ABCG2 (0.47) KMT2ANPC1RAB9AALDH1A1MEN1
SCHEMBL31428515 0.80 CYP1A2 (0.46) HPGDKMT2ANPC1HSP90AA1RAB9A
SCHEMBL31428671 0.80 HPGD (0.50) HPGDCYP1A2CYP3A4CYP2C9LMNA
SCHEMBL24977053 0.77 ACACB (0.44) HPGDACACBACACAALDH1A1MAPT
SCHEMBL31428743 0.77 ACACB (0.44) HPGDACACBACACAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS HPGD 4233/4885KMT2A 2837/4885NPC1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.